- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07406516
Identifikation af kinematiske variabler specifikke for patellartendinopati hos atleter i risikogruppen (TENVOL)
Identifikation af kinematiske variabler specifikke for patellartendinopati hos atleter i risiko
This research aims to identify and monitor specific kinematic markers associated with patellar tendinopathy in athletes at risk. Using a markerless motion capture system, vertical jump tests will be analyzed to detect early biomechanical changes in the knees, hips, trunk, and ankles. By comparing injured participants, the study seeks to improve early diagnosis and personalized prevention strategies for patellar tendinopathy.
Studieoversigt
Status
Intervention / Behandling
- Diagnostisk test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.
- Diagnostisk test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology at 6 months and 12 months
Detaljeret beskrivelse
Patellar tendinopathy, also known as Jumper's knee, is the most common pathology in elite sports, with 30% of diagnoses occurring in volleyball. Among elite volleyball players, the prevalence of this overuse-related condition ranges between 40% and 50%, resulting in anterior knee pain during daily and recreational activities, which can lead to deficits in strength and sports performance. To date, investigator can determine whether a patient has had a history of tendinopathy through modifications in biomechanical jump-landing strategies. However, there is a lack of early biomechanical markers to identify the onset of patellar tendinopathy and thus prevent its chronic progression. A preventive strategy using markerless motion capture technology, providing quantitative and visual feedback of a 3D human body model, shows promise. Investigators hypothesize that jump-landing kinematic analysis using markerless technology could identify early kinematic markers specific to patellar tendinopathy, distinguishing affected individuals from a non-tendinopathy population. This could ultimately help identify motor strategies following the onset of patellar tendinopathy A prospective longitudinal multicenter cohort. After signing the consent form, participants will undergo a medical examination, including a clinical assessment, a SLDS test, a Doppler ultrasound of the patellar tendon, and evaluation using the VISA-PF and OSTRC-P scores. Following a standardized 10-minute warm-up, participants will perform vertical jump tests captured by high-resolution cameras, analyzed using markerless motion capture technology. These assessments will be conducted at inclusion and at 3, 6, 9, and 12 months. Additional medical visits will occur if symptoms arise outside of testing.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Benjamin BEN ZAKI
- Telefonnummer: +336 66 09 13 43
- E-mail: b-benzaki@chu-montpellier.fr
Studiesteder
-
-
-
Montpellier, Frankrig
- Rekruttering
- Sports Medicine and Traumatology LAPEYRONIE Hospital - Montpellier University Hospital
-
Kontakt:
- Benjamin BEN ZAKI
- Telefonnummer: +336 66 09 13 43
- E-mail: b-benzaki@chu-montpellier.fr
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
- Subject aged between 18 and 45 years
- Male subject
- Regularly participating in physical activity involving jumping (a predisposing factor for patellar tendinopathy) twice a week for at least one year.
- Participants affiliated with or covered by a social security scheme
SPECIFIC INCLUSION CRITERIA FOR THE PATELLAR TENDINOPATHY GROUP
Patients with at least 2 of the following 3 criteria:
- Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
- VISA-PF < 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
- Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)
SPECIFIC INCLUSION CRITERIA FOR THE HEALTHY GROUP
Patients with 0 or 1 of the following 3 criteria:
- Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
- VISA-PF < 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
- Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)
Non inclusion Criteria:
- Significant medical and surgical history involving the lower limbs (e.g., ACL ligament reconstruction, meniscectomy, etc.)
- Contraindications to participating in sports activities
- Other pathologies involving the lower limbs (< 6 months), e.g., torn knee ligaments, ankle sprain, knee sprain, etc.
- Participants who have not given their informed consent
- Participants subject to legal protection measures (legal guardianship, conservatorship, curatorship)
- Participants deprived of their liberty by judicial or administrative decision
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: patellar tendinopathy group
Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology. |
Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods (M3, M6, M9, M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy. |
|
Andet: healthy group
Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology. |
Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods ( M6 et M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Variations of knee flexion angle at initial contact at 3 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of knee flexion angle at initial contact at 6 months
Tidsramme: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of knee flexion angle at initial contact at 9 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of knee flexion angle at initial contact at 12 months
Tidsramme: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the maximum knee flexion angle at 3 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the maximum knee flexion angle at 6 months
Tidsramme: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the maximum knee flexion angle at 9 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the maximum knee flexion angle at 12 months
Tidsramme: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 3 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months
Tidsramme: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 9 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 12 months
Tidsramme: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 3 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months
Tidsramme: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 9 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 12 months
Tidsramme: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Comparison of variation between healthy group and patellar tendinopathy group of knee flexion angle at initial contact at 6 months
Tidsramme: Between the two 6-month visits of the two groups
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the two 6-month visits of the two groups
|
|
Comparison between the healthy group and the patellar tendinopathy group of variation of the maximum knee flexion angle at 6 months
Tidsramme: Between the two 6-month visits of the two groups
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the two 6-month visits of the two groups
|
|
Comparison between the healthy group and the patellar tendinopathy group of variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months
Tidsramme: Between the two 6-month visits of the two groups
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the two 6-month visits of the two groups
|
|
Comparison between the healthy group and the patellar tendinopathy group of variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months
Tidsramme: Between the two 6-month visits of the two groups
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the two 6-month visits of the two groups
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 3 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 6 months
Tidsramme: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 9 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 12 months
Tidsramme: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 3 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 6 months
Tidsramme: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 9 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 12 months
Tidsramme: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 3 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 6 months
Tidsramme: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 9 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 12 months
Tidsramme: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 3 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 6 months
Tidsramme: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 9 months (only for patients in the patellar tendinopathy group)
Tidsramme: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 12 months
Tidsramme: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- RECHMPL25_0117
- 2025-A01948-41 (Registry Identifier: IdRCB)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .